112 related articles for article (PubMed ID: 33459066)
21. Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.
Feng Y; Wu L
Int J Clin Exp Pathol; 2020; 13(1):99-106. PubMed ID: 32055278
[TBL] [Abstract][Full Text] [Related]
22. EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma.
Huang R; Nie W; Mi L; Yao C; Zhu H
Aging (Albany NY); 2024 Apr; 16(8):7311-7330. PubMed ID: 38687509
[TBL] [Abstract][Full Text] [Related]
23. Eukaryotic translation initiation factor 3B downregulation inhibits cell proliferation and promotes cell apoptosis through negatively regulating tumor necrosis factor receptor superfamily member 21 in gastric cancer.
Xiong H; Hu M; Huang H; Gong J; Wu J; Zhang H
Transl Cancer Res; 2019 Oct; 8(6):2242-2251. PubMed ID: 35116977
[TBL] [Abstract][Full Text] [Related]
24. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.
Huang L; He K; Wang J; Yan J; Jiang Y; Wei Z; Zhang J; Li G; Sheng L
Adv Clin Exp Med; 2019 Dec; 28(12):1639-1645. PubMed ID: 31778600
[TBL] [Abstract][Full Text] [Related]
26. EIF3B stabilizes PTGS2 expression by counteracting MDM2-mediated ubiquitination to promote the development and progression of malignant melanoma.
Fang P; Han Y; Qu Y; Wang X; Zhang Y; Zhang W; Zhang N; Li G; Ma W
Cancer Sci; 2022 Dec; 113(12):4181-4192. PubMed ID: 36050601
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of EIF3H inhibits the development and progression of pancreatic cancer by regulating cell proliferation and apoptosis in vitro.
Shan Y; Kong W; Zhu A; Li J; Jin H; Zhu W
Cell Mol Biol (Noisy-le-grand); 2022 Jan; 67(4):83-90. PubMed ID: 35809300
[TBL] [Abstract][Full Text] [Related]
28. The expression of eukaryotic translation initiation factor 3B and its correlation with tumor characteristics as well as prognosis in non-small cell lung cancer patients: a retrospective study.
Liu C; Li X; Tian J; Zhang S; Liu Y; Zhai X; Feng Q
J BUON; 2020; 25(5):2350-2357. PubMed ID: 33277855
[TBL] [Abstract][Full Text] [Related]
29. EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients.
Zhu F; Fu Y; He X
Technol Cancer Res Treat; 2021; 20():15330338211041464. PubMed ID: 34617851
[No Abstract] [Full Text] [Related]
30. Eukaryotic initiation factor 3B downregulation suppresses cell proliferation, migration and invasion while it induces cell apoptosis by blocking the β-catenin pathway in endometrial cancer.
Min J; Chen H
Int J Clin Exp Pathol; 2019; 12(9):3595-3603. PubMed ID: 31934209
[TBL] [Abstract][Full Text] [Related]
31. Novel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).
Yue MM; Lv K; Meredith SC; Martindale JL; Gorospe M; Schuger L
J Biol Chem; 2014 Dec; 289(49):33971-83. PubMed ID: 25336651
[TBL] [Abstract][Full Text] [Related]
32. Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes Cell Proliferation and Motility in Pancreatic Cancer.
Wang SQ; Liu Y; Yao MY; Jin J
J Korean Med Sci; 2016 Oct; 31(10):1586-94. PubMed ID: 27550487
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of CDCA3 expression inhibits tumor formation in pancreatic cancer.
Zou RC; Guo ZT; Wei D; Shi ZT; Ye ZC; Zhai G; Zhong C; Tang B; Wang L; Ge JY
Neoplasma; 2020 Nov; 67(6):1223-1232. PubMed ID: 32701354
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
35. High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.
Li WG; Yuan YZ; Qiao MM; Zhang YP
World J Gastroenterol; 2012 Jun; 18(21):2630-9. PubMed ID: 22690071
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of KDM1B inhibits cell proliferation and induces apoptosis of pancreatic cancer cells.
Wang Y; Sun L; Luo Y; He S
Pathol Res Pract; 2019 May; 215(5):1054-1060. PubMed ID: 30846414
[TBL] [Abstract][Full Text] [Related]
37. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
Zhu H; Qin H; Li DM; Liu J; Zhao Q
Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
[TBL] [Abstract][Full Text] [Related]
38. Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
Zang Y; Zhang X; Yan L; Gu G; Li D; Zhang Y; Fang L; Fu S; Ren J; Xu Z
J Cancer; 2017; 8(15):3049-3061. PubMed ID: 28928896
[TBL] [Abstract][Full Text] [Related]
39. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
Han GY; Cui JH; Liang S; Li HL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
[TBL] [Abstract][Full Text] [Related]
40. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
